Intracoronary administration of autologous mesenchymal stem cells in a critically ill patient with dilated cardiomyopathy

Pediatric Transplantation

Volumn 15, Issue 8, 2011, Pages

  Zeinaloo, Aliakbar ^a   Zanjani, Keyhan S ^a   Bagheri, Mohammad M ^a   Mohyeddin Bonab, Mandana ^a   Monajemzadeh, Maryam ^a   Arjmandnia, Mohammad H ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

biopsy; cardiomyopathy; children; stem cell administration

Indexed keywords

ANAMNESIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW; CASE REPORT; CHILD; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CRITICALLY ILL PATIENT; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART MUSCLE BIOPSY; HUMAN; MALE; MESENCHYMAL STEM CELL; QUALITY OF LIFE; RISK ASSESSMENT; SCHOOL CHILD; TREATMENT OUTCOME;

CARDIOMYOPATHY, DILATED; CHILD; CORONARY VESSELS; ECHOCARDIOGRAPHY; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIUM;

EID: 82155191361     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2010.01366.x     Document Type: Article

References (18)

1. Canter CE, Shaddy RE, Bernstein D, et al., Indications for heart transplantation in pediatric heart disease: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007: 115: 658-676. (Pubitemid 46230817)
2. Daubeney PEF, Nugent AW, Chondros P, et al., Clinical features and outcomes of childhood dilated cardiomyopathy: Results from a national population-based study. Circulation 2006: 114: 2671-2678. (Pubitemid 44967351)
3. Arabi Moghaddam MY, Zanjani KS,. A follow-up study of 115 children with dilated cardiomyopathy. J Iran Univ Med Sci 2007: 13: 7-13. [Article in Persian]
4. Assmus B, Honold J, Schächinger V, et al., Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006: 355: 1222-1232. (Pubitemid 44427446)
5. Schächinger V, Erbs S, Elsässer A, et al., Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N EngI J Med 2006: 355: 1210-1221. (Pubitemid 44427445)
6. Mohyeddin-Bonab M, Mohamad-Hasani M, Alimoghaddam K, et al., Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction. Arch Iranian Med 2007: 10: 467-473. (Pubitemid 350001897)
7. Orlic D, Kajstura J, Chimenti S, et al., Bone marrow cells regenerate infarcted myocardium. Nature 2001: 410: 701-705. (Pubitemid 32290358)
8. Qian C, Tio RA, Roks AJ, et al., A promising technique for transplantation of bone marrow-derived endothelial progenitor cells into rat heart. Cardiovasc Pathol 2007: 16: 127-135. (Pubitemid 46720017)
9. Grøgaard HK, Sigurjonsson OE, Brekke M, et al., Cardiac accumulation of bone marrow mononuclear progenitor cells after intracoronary or intravenous injection in pigs subjected to acute MI with subsequent reperfusion. Cardiovasc Revasc Med 2007: 8: 21-27. (Pubitemid 46216174)
10. Strauer BE, Brehm M, Zeus T, et al., Repair of Infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002: 106: 1913-1918. (Pubitemid 35176294)
11. Wollert KC, Meyer GP, Lotz J, et al., Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004: 364: 141-148. (Pubitemid 38891685)
12. Lunde K, Solheim S, Aakhus S, et al., Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: Results from the Autologous Stem Cell Transplantation in Acute MI (ASTAMI) randomized controlled trial. Am Heart J 2007: 154: 710. e1-8.
13. Rupp S, Bauer J, Tonn T, et al., Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old-child with dilated cardiomyopathy. Pediatr Transplant 2009: 13: 620-623.
14. Argüero R, Careaga-Reyna G, Castaño-Guerra R, Garrido-Garduño MH, Magaña-Serrano JA, De Jesús Nambo-Lucio M,. Cellular autotransplantation for ischemic and idiopathic dilated cardiomyopathy. Preliminary report. Arch Med Res 2006: 37: 1010-1014. (Pubitemid 44512065)
15. Kaparthi PLN, Namita G, Chelluri LK, et al., Autologous bone marrow mononuclear cell delivery to dilated cardiomyopathy patients: A clinical trial. African J Biotechnol 2008: 7: 207-210. (Pubitemid 351239891)
16. Strauer BE, Brehm M, Schannwell CM,. The therapeutic potential of stem cells in heart disease. Cell Prolif 2008: 41 (Suppl. 1): 126-145. (Pubitemid 350295849)
17. Lionetti V, Bianchi G, Recchia FA, Ventura C,. Control of autocrine and paracrine myocardial signals: An emerging therapeutic strategy in heart failure. Heart Fail Rev 2010 Apr 3: [Epub ahead of print].
18. Nakanishi C, Yamagishi M, Yamahara K, et al., Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem Biophys Res Commun 2008: 374: 11-16.